Stock Analiz

Tandem Diabetes Care Inc. (TNDM) financials: revenue, earnings and cash flow

Fiscal 2016–2025 + TTM · from SEC filings · data as of November 13, 2026

Summary

Tandem Diabetes Care’s revenue went from $84M in fiscal 2016 to $1.0B in fiscal 2025, growth of about 31.9% a year.

Net income in fiscal 2025 was -$205M, a net margin of -20.2%; the best year in this period was 2021 with $16M.

Over the twelve months to September 30, 2026, revenue was $1.1B and net income -$49M.

Free cash flow was -$30M in fiscal 2025 and positive in 4 of the 10 years shown.

The diluted share count rose 2101% over the period (dilution).

Revenue, profit and cash flow by year

Revenue
2016: $84M162017: $108M172018: $184M182019: $362M192020: $499M202021: $703M212022: $801M222023: $748M232024: $940M242025: $1.0B25$1.0B
Net income
2016: -$83M162017: -$73M172018: -$123M182019: -$25M192020: -$34M202021: $16M212022: -$95M222023: -$223M232024: -$96M242025: -$205M25-$205M
Free cash flow
2016: -$70M162017: -$72M172018: -$11M182019: $22M192020: -$3M202021: $97M212022: $16M222023: -$59M232024: $5M242025: -$30M25-$30M
EPS (diluted)
2016: $-27.30162017: $-12.87172018: $0.02182019: $-0.42192020: $-0.56202021: $0.24212022: $-1.47222023: $-3.43232024: $-1.47242025: $-3.0425$-3.04

Income statement

Fiscal yearTTM2025202420232022202120202019201820172016
Revenue$1.1B$1.0B$940M$748M$801M$703M$499M$362M$184M$108M$84M
Gross profit$609M$546M$490M$368M$413M$376M$261M$194M$90M$44M$24M
Operating income-$25M-$187M-$99M-$233M-$93M$23M-$8M-$17M-$45M-$63M-$78M
Net income-$49M-$205M-$96M-$223M-$95M$16M-$34M-$25M-$123M-$73M-$83M
EPS (diluted)$-0.70$-3.04$-1.47$-3.43$-1.47$0.24$-0.56$-0.42$0.02$-12.87$-27.30
R&D$188M$193M$199M$170M$139M$92M$64M$45M$29M$21M$19M
Revenue growth—+7.9%+25.7%−6.7%+14.0%+40.9%+37.7%+97.0%+70.9%+27.7%+15.7%

Cash flow

Fiscal yearTTM2025202420232022202120202019201820172016
Operating cash flow-$15M-$10M$24M-$32M$50M$111M$25M$42M-$8M-$66M-$61M
Capital spending-$22M-$20M-$19M-$27M-$34M-$14M-$27M-$20M-$3M-$6M-$9M
Free cash flow-$36M-$30M$5M-$59M$16M$97M-$3M$22M-$11M-$72M-$70M
Dividends paid—$0$0$0$0$0$0$0$0$0$0
Buybacks—$0$30M$0$0——————
Stock-based pay$67M$92M$101M$88M$85M$61M$58M$58M$24M$13M$12M

Balance sheet

Fiscal yearTTM2025202420232022202120202019201820172016
Cash—$293M$438M$468M$617M$624M$485M$176M$129M$14M$54M
Debt—$444M$474M$416M$420M$315M$228M$20M—$83M$81M
Equity—$155M$263M$314M$440M$433M$366M$195M$131M-$29M-$6M
Total assets—$881M$968M$953M$1.1B$905M$716M$326M$206M$95M$112M
Shares (diluted)70M67M65M65M64M64M61M59M48M6M3M

Margins and returns

Fiscal yearTTM2025202420232022202120202019201820172016
Gross margin56.6%53.8%52.1%49.2%51.5%53.5%52.2%53.6%48.9%41.0%28.0%
Operating margin-2.4%-18.4%-10.5%-31.2%-11.6%3.2%-1.6%-4.6%-24.3%-58.5%-92.6%
Net margin-4.6%-20.2%-10.2%-29.8%-11.8%2.2%-6.9%-6.8%-66.7%-67.9%-99.1%
FCF margin-3.4%-2.9%0.5%-7.8%2.0%13.8%-0.5%6.2%-6.2%-66.8%-83.2%
ROIC—-24.7%-10.6%-25.3%-8.5%3.0%-1.3%-6.1%-26.9%-92.8%-103.8%
ROE—-131.9%-36.5%-71.0%-21.5%3.6%-9.4%-12.7%-93.4%250.6%1407.9%

Frequently asked questions

What is Tandem Diabetes Care’s annual revenue?

$1.0B in fiscal 2025 and $1.1B over the twelve months to September 30, 2026.

How much profit does Tandem Diabetes Care make?

Net income was -$205M in fiscal 2025 (net margin -20.2%).

Is Tandem Diabetes Care’s revenue growing?

Yes: revenue rose 7.9% in fiscal 2025 compared with the year before.

From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.